tradingkey.logo

Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition

ReutersMay 19, 2025 12:35 PM

- Prime Medicine Inc PRME.O:

  • PRIME MEDICINE ANNOUNCES STRATEGIC RESTRUCTURING TO FOCUS ON OPPORTUNITIES IN LARGE GENETIC LIVER DISEASES, CYSTIC FIBROSIS, AND PARTNERED PROGRAMS ALONGSIDE CEO LEADERSHIP TRANSITION

  • PRIME MEDICINE INC - TO REDUCE HEADCOUNT BY 25%

  • PRIME MEDICINE INC - ALLAN REINE APPOINTED CEO OF PRIME MEDICINE

  • PRIME MEDICINE INC - IN ARBITRATION WITH BEAM THERAPEUTICS OVER AATD PROGRAM

  • PRIME MEDICINE INC: KEITH GOTTESDIENER TO STEP DOWN AS CEO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI